Parunya Chaiyawat

发表

Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma

Areerak Phanphaisarn, Jeerawan Klangjorhor, Parunya Chaiyawat, 2019, Journal of bone oncology.

Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway

J. Svasti, C. Srisomsap, D. Chokchaichamnankit, 2019, International journal of oncology.

Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature

O. Arpornchayanon, Areerak Phanphaisarn, Jeerawan Klangjorhor, 2018, Journal of bone oncology.

Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent.

N. Koonrungsesomboon, Juthipong Benjanuwattra, Parunya Chaiyawat, 2020, European journal of pharmacology.

Prevalence and Survival Patterns of Patients with Bone Metastasis from Common Cancers in Thailand.

Areerak Phanphaisarn, Jeerawan Klangjorhor, Parunya Chaiyawat, 2016, Asian Pacific journal of cancer prevention : APJCP.

In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients

N. Theera-Umpon, Phichayut Phinyo, Areerak Phanphaisarn, 2020, Cancer Chemotherapy and Pharmacology.

Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma

C. Srisomsap, D. Chokchaichamnankit, P. Pothacharoen, 2016, International journal of oncology.

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

J. Svasti, C. Srisomsap, D. Chokchaichamnankit, 2021, Glycoconjugate Journal.

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand

D. Pongnikorn, Areerak Phanphaisarn, N. Waisri, 2022, Scientific Reports.

IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma

Phichayut Phinyo, Areerak Phanphaisarn, Jeerawan Klangjorhor, 2021, Scientific Reports.

Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction

S. Chutipongtanate, Parunya Chaiyawat, Dumnoensun Pruksakorn, 2022, International journal of molecular sciences.

Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma

Areerak Phanphaisarn, Jeerawan Klangjorhor, Parunya Chaiyawat, 2020, Journal of bone oncology.

Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression

P. Kongtawelert, Phichayut Phinyo, P. Pothacharoen, 2022, Biology.

Relationship Between O-GlcNAcase Expression and Prognosis of Patients With Osteosarcoma

C. Supanchart, S. Krisanaprakornkit, T. Sastraruji, 2020, Applied immunohistochemistry & molecular morphology : AIMM.

Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review

Phichayut Phinyo, Sasimol Udomruk, S. Orrapin, 2022, Cancers.

Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.

K. Kanokwiroon, Apiwat Sangphukieo, Jeerawan Klangjorhor, 2022, Gene.

AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand.

D. Pongnikorn, Areerak Phanphaisarn, K. Daoprasert, 2016, Asian Pacific journal of cancer prevention : APJCP.

Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma

Luca Lo Piccolo, Parunya Chaiyawat, Dumnoensun Pruksakorn, 2021, Cancers.

Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications

Areerak Phanphaisarn, Jeerawan Klangjorhor, Parunya Chaiyawat, 2017, Modern Pathology.

Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment

Kriengsak Lirdprapamongkol, Areerak Phanphaisarn, Jeerawan Klangjorhor, 2020, International journal of cancer.

Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcoma

C. Srisomsap, Kriengsak Lirdprapamongkol, Areerak Phanphaisarn, 2018, Cancer Chemotherapy and Pharmacology.

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma

V. Champattanachai, Areerak Phanphaisarn, Jeerawan Klangjorhor, 2017, Translational oncology.

Genomics-Driven Precision Medicine in Pediatric Solid Tumors

S. Chutipongtanate, W. Chiangjong, S. Hongeng, 2023, Cancers.

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial

P. Charoenkwan, N. Ngamphaiboon, N. Townamchai, 2020, BMC Cancer.

An analysis of the incidence and survival rates of bone sarcoma patients in thailand: reports from population-based cancer registries 2001-2015.

S. Sangrajrang, D. Pongnikorn, Sasimol Udomruk, 2021, Cancer epidemiology.

The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer

B. Chewaskulyong, Sasimol Udomruk, S. Orrapin, 2023, International journal of molecular sciences.

Proteomic analysis and abrogated expression of O‐GlcNAcylated proteins associated with primary breast cancer

C. Srisomsap, D. Chokchaichamnankit, P. Punyarit, 2013, Proteomics.

Safety and efficacy of intralesional steroid injection for aggressive fibromatosis

O. Arpornchayanon, N. Kosachunhanun, Areerak Phanphaisarn, 2017, World Journal of Surgical Oncology.

Exploring targeted therapy of osteosarcoma using proteomics data

Jeerawan Klangjorhor, Parunya Chaiyawat, Dumnoensun Pruksakorn, 2017, OncoTargets and therapy.

Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.

C. Srisomsap, D. Chokchaichamnankit, Kriengsak Lirdprapamongkol, 2018, Oncology reports.

Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer

V. Champattanachai, Parunya Chaiyawat, P. Netsirisawan, 2014, Front. Endocrinol..

Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis

Areerak Phanphaisarn, A. Tantraworasin, Jeerawan Klangjorhor, 2017, Journal of bone oncology.

Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.

C. Srisomsap, D. Chokchaichamnankit, P. Punyarit, 2013, Oncology reports.

Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells.

C. Srisomsap, D. Chokchaichamnankit, V. Champattanachai, 2016, Cancer genomics & proteomics.

High-Throughput Screening of Alternative Micro-Metastasis-Specific Gene Predictors of Circulating Osteosarcoma Cells

P. Kongtawelert, Phichayut Phinyo, P. Pothacharoen, 2021 .

P. Charoenkwan, N. Ngamphaiboon, N. Townamchai, 2020, BMC Cancer.

Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.

C. Srisomsap, D. Chokchaichamnankit, Kriengsak Lirdprapamongkol, 2015, Oncology reports.

Size Distribution of Cell-free DNA in Oncology.

Sasimol Udomruk, S. Orrapin, Parunya Chaiyawat, 2021, Critical reviews in oncology/hematology.

Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer

Sasimol Udomruk, Parunya Chaiyawat, Dumnoensun Pruksakorn, 2023, International journal of molecular sciences.